Page last updated: 2024-11-02

pioglitazone and Idiopathic Inflammatory Myopathies

pioglitazone has been researched along with Idiopathic Inflammatory Myopathies in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joya-Galeana, J1
Fernandez, M1
Cervera, A1
Reyna, S1
Ghosh, S1
Triplitt, C1
Musi, N1
DeFronzo, RA1
Cersosimo, E1

Trials

1 trial available for pioglitazone and Idiopathic Inflammatory Myopathies

ArticleYear
Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
    Diabetes/metabolism research and reviews, 2011, Volume: 27, Issue:4

    Topics: Adult; Body Mass Index; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabet

2011